Hamelin BA[au] - Search Results

Year	Number of Results
1992	2
1993	1
1994	1
1996	1
1997	2
1998	5
1999	5
2000	2
2001	1
2003	2
2004	2
2005	3
2006	1
2009	1
2010	2
2011	1
2012	1
2023	0

1

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors.

Hamelin BA, Turgeon J. Hamelin BA, et al. Trends Pharmacol Sci. 1998 Jan;19(1):26-37. doi: 10.1016/s0165-6147(97)01147-4. Trends Pharmacol Sci. 1998. PMID: 9509899 Review.

2

Cefepime pharmacokinetics in cystic fibrosis.

Hamelin BA, Moore N, Knupp CA, Ruel M, Vallée F, LeBel M. Hamelin BA, et al. Pharmacotherapy. 1993 Sep-Oct;13(5):465-70. Pharmacotherapy. 1993. PMID: 8247913 Clinical Trial.

3

Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.

Sharma A, Hamelin BA. Sharma A, et al. Among authors: hamelin ba. Curr Drug Metab. 2003 Apr;4(2):105-29. doi: 10.2174/1389200033489523. Curr Drug Metab. 2003. PMID: 12678691 Review.

4

Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.

O'Hara GE, Philippon F, Gilbert M, Champagne J, Michaud V, Charbonneau L, Pruneau G, Hamelin BA, Geelen P, Turgeon J. O'Hara GE, et al. Among authors: hamelin ba. J Clin Pharmacol. 2012 Feb;52(2):171-9. doi: 10.1177/0091270011399574. J Clin Pharmacol. 2012. PMID: 21508180 Clinical Trial.

5

Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction.

Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, Bélanger PM, Meibohm B, Hamelin BA. Sharma A, et al. Among authors: hamelin ba. J Clin Pharmacol. 2010 Feb;50(2):214-25. doi: 10.1177/0091270009340417. Epub 2009 Nov 30. J Clin Pharmacol. 2010. PMID: 19948945 Clinical Trial.

6

Fleroxacin pharmacokinetics in patients with liver cirrhosis.

Blouin RA, Hamelin BA, Smith DA, Foster TS, John WJ, Welker HA. Blouin RA, et al. Among authors: hamelin ba. Antimicrob Agents Chemother. 1992 Mar;36(3):632-8. doi: 10.1128/AAC.36.3.632. Antimicrob Agents Chemother. 1992. PMID: 1622175 Free PMC article.

7

The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.

Hamelin BA, Turgeon J, Vallée F, Bélanger PM, Paquet F, LeBel M. Hamelin BA, et al. Clin Pharmacol Ther. 1996 Nov;60(5):512-21. doi: 10.1016/S0009-9236(96)90147-2. Clin Pharmacol Ther. 1996. PMID: 8941024

8

CYP2D6 mutations and therapeutic outcome in schizophrenic patients.

Hamelin BA, Dorson PG, Pabis D, Still D, Bouchard RH, Pourcher E, Rail J, Turgeon J, Crismon ML. Hamelin BA, et al. Pharmacotherapy. 1999 Sep;19(9):1057-63. doi: 10.1592/phco.19.13.1057.31593. Pharmacotherapy. 1999. PMID: 10610012 Clinical Trial.

9

Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent.

Hamelin BA, Zakrzewski-Jakubiak M, Robitaille NM, Bogaty P, Labbé L, Turgeon J. Hamelin BA, et al. J Clin Pharmacol. 2011 Sep;51(9):1286-92. doi: 10.1177/0091270010382420. Epub 2010 Dec 8. J Clin Pharmacol. 2011. PMID: 21148050

10

Caffeine metabolism in cystic fibrosis: enhanced xanthine oxidase activity.

Hamelin BA, Xu K, Vallé F, Manseau L, Richer M, LeBel M. Hamelin BA, et al. Clin Pharmacol Ther. 1994 Nov;56(5):521-9. doi: 10.1038/clpt.1994.173. Clin Pharmacol Ther. 1994. PMID: 7955816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results